Obesity and Perioperative Morbidity in Total Hip and Total Knee Arthroplasty Patients
Section snippets
Definitions of Obesity
A BMI of greater than 30 is a widely accepted measurement of obesity 1, 2. In this study, we further designated patients as being “highly obese” if their BMI exceeded 35. Categorizing patients with a BMI greater than 35 has been found to stratify differences among patients undergoing TKA [9]. A BMI greater than 40 is defined as morbid obesity.
Patient Samples
Patients were identified using a prospective registry that records patient demographics and comorbidities, details on the surgical procedure, implant
Results
Obesity (BMI ≥30) was more prevalent in TKA patients (52%) than THA patients (36%, P < .001). TKA patients were also more likely to be highly obese (BMI ≥35; 23%) than THA patients (14%, P < .001). Similarly, morbid obesity (BMI ≥40) was more prevalent in TKA (11%) than THA (5%) patients (P < .001).
Table 1, Table 2 present patient demographics, comorbidities, and outcomes for highly obese (BMI ≥35) and non–highly obese (BMI ≤35) patients who underwent THA or TKA. The highly obese THA and TKA
Discussion
The prevalence of obesity in patients undergoing elective orthopedic procedures is high but is particularly high for the knee joint 1, 2, 3. The prevalence of obesity (BMI ≥30) in the United States is estimated to be 30% in the general population [14]. In our series, 52% of the TKA patients were obese, considerably higher than the national average. The TKA patients with BMI 35 or higher (highly obese) were significantly younger, further supporting the strong association of obesity and knee
References (20)
- et al.
Does body weight influence outcome after total knee arthroplasty? A 1 year analysis
J Arthroplasty
(2002) - et al.
Cementless total knee arthroplasty in obese patients. A comparison with a matched control group
J Arthroplasty
(1996) Prevalence of obesity among patients admitted for elective orthopedic surgery
Int J Obes Relat Metab Disord
(1994)Prevalence of obesity among patients admitted for elective orthopedic surgery
Int J Obesity
(1994)- et al.
J Orthop Res
(2000) - et al.
A comparison of perioperative morbidity in total joint arthroplasty in the obese and nonobese patient
Clin Orthop
(1993) - et al.
Total knee arthroplasty in patients who were obese with 10 years followup
Clin Orthop
(1998) - et al.
Total knee arthroplasty in morbidly obese patients
J Bone Joint Surg
(1998) - et al.
Perioperative morbidity following total knee arthroplasty among obese patients
J Knee Surg
(2002) - et al.
Patient comorbidity: relationship to outcomes of total knee arthroplasty
Clin Orthop Rel Res
(1998)
Cited by (372)
Semaglutide and Other GLP-1 Agonists: A Boon for the Arthroplasty Industry?
2024, Journal of ArthroplastyEvaluation of weight loss counsel for Osteoarthritis patients: A cross-sectional analysis of NHANES 2011–2018
2024, Osteoarthritis and CartilageFunctional recovery after total hip/knee replacement in obese people: A systematic review
2023, Annals of Physical and Rehabilitation MedicineThe Impact of Metabolic Syndrome on Reoperations and Complications After Primary Total Hip Arthroplasty
2022, Journal of ArthroplastyChronic Thrombocytopenia and In-Hospital Outcomes After Primary Total Hip and Knee Arthroplasty
2022, Journal of Arthroplasty
All of authors received support in the form of an unrestricted research grant from Depuy, Zimmer, and Smith and Nephew.